Cita APA

Fowler, N. H., Davis, R. E., Rawal, S., Nastoupil, L., Hagemeister, F. B., McLaughlin, P., . . . Neelapu, S. S. (2014). Safety, activity, and immune effects of lenalidomide and rituximab in untreated indolent lymphoma. Lancet Oncol.

Citación estilo Chicago

Fowler, Nathan H., et al. "Safety, Activity, and Immune Effects of Lenalidomide and Rituximab in Untreated Indolent Lymphoma." Lancet Oncol 2014.

Cita MLA

Fowler, Nathan H., et al. "Safety, Activity, and Immune Effects of Lenalidomide and Rituximab in Untreated Indolent Lymphoma." Lancet Oncol 2014.